Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 487   Home Print this page  Email this page Small font size Default font size Increase font size


 
Table of Contents
ERRATUM
Year : 2020  |  Volume : 12  |  Issue : 4  |  Page : 396  

Erratum: Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography


Date of Web Publication15-Oct-2020

Correspondence Address:
Login to access the Email id


DOI: 10.4103/0974-7796.250559

Rights and Permissions

How to cite this article:
. Erratum: Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography. Urol Ann 2020;12:396

How to cite this URL:
. Erratum: Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography. Urol Ann [serial online] 2020 [cited 2020 Oct 29];12:396. Available from: https://www.urologyannals.com/text.asp?2020/12/4/396/250559



In the article titled “Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specifi c membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography”, published on pages 155-162, Issue 2, Volume 11 of Urology Annals,[1] the affiliation of Manoj Gupta is written incorrectly as “Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India” instead of “Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India and Amity Centre for Radiation Biology, Amity University, Noida, Uttar Pradesh, India”.

The correct list of authors and their affiliations should read as below:

Manoj Gupta1,3, Partha Sarathi Choudhury1, Sudhir Rawal2, Harish Chandra Goel3, Shriram Avinash Rao4xs

1 Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India

2 Department of Uro-Gynae Surgical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India

3 Amity Centre for Radiation Biology, Amity University, Noida, Uttar Pradesh, India

4 Department of Radiology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India



 
   References Top

1.
Gupta M, Choudhury PS, Rawal S, Goel HC, Rao SA. Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography. Urol Ann 2019;11:155-62.  Back to cited text no. 1
[PUBMED]  [Full text]  




 

Top
 
  Search
 
    Similar in PUBMED
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed37    
    Printed0    
    Emailed0    
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal